Quick Search

 

 


 

 

Result Summary for 112300

Result Summary
Protocol ID: 112300
Clinical Study ID: OTH112300
Official Title: Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg
Phase: phase 4
Study Indications or Diseases:
  • Cardiovascular Disease
Generic Name: epoprostenol
Trade/Product Name: Flolan
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.